Loading…
Nuvation Bio Inc. is projected to rise to $11.02 by 2027, a +65% move from its current price of $6.70. NUVB is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $6.51 | $6.71 | $6.90 | +0.08% |
| Aug 2 | $6.44 | $6.71 | $6.99 | +0.16% |
| Aug 3 | $6.38 | $6.72 | $7.07 | +0.24% |
| Aug 4 | $6.34 | $6.72 | $7.13 | +0.32% |
| Aug 5 | $6.30 | $6.73 | $7.18 | +0.40% |
| Aug 6 | $6.27 | $6.73 | $7.23 | +0.48% |
| Aug 7 | $6.23 | $6.74 | $7.28 | +0.56% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.23 | $6.74 | $7.28 | +0.56% |
| Week 2 | $6.07 | $6.78 | $7.56 | +1.12% |
| Week 3 | $5.96 | $6.81 | $7.79 | +1.69% |
| Week 4 | $5.87 | $6.85 | $8.00 | +2.25% |
| Week 5 | $5.79 | $6.89 | $8.19 | +2.83% |
| Week 6 | $5.73 | $6.93 | $8.38 | +3.40% |
| Week 7 | $5.67 | $6.97 | $8.55 | +3.98% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Nuvation Bio Inc. is a clinical-stage biopharmaceutical company focused on developing product candidates for cancer treatment. Its lead product candidate is IBTROZI (taletrectinib), a ROS1 inhibitor for ROS1+ non-small cell lung cancer.
It is also developing Safusidenib, an inhibitor of mutant isocitrate dehydrogenase 1 in phase 3 clinical trials for the maintenance treatment of high-risk or high-grade IDH1-mutant astrocytoma with safusidenib against placebo. The company was founded in 2018 and is headquartered in New York, New York.
NUVB is the stock with a current price of $6.70 and a market cap of $2.33B, ranked 1807 by market capitalization.
The 30-day range is $5.52 to $8.13.
In the near term, the 2026 forecast shows a min of $4.05, an avg of $6.70, and a max of $10.12, with a neutral sentiment and ROI 0.
From 2027 onward, the forecast portrays bullish sentiment and a rising path: 2027 avg $11.02; 2028 avg $13.33; 2029 avg $14.88; 2030 avg $17.88; 2040 avg $66.27; 2050 avg $157.88.
A major floor 39.6% below — a decisive break under it would weaken the trend.
The nearest floor, 20.4% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 13.6% above — clearing it would confirm fresh momentum.
Key NUVB support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NUVB market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.61 | Buy | $6.60 | Buy |
| MA 10 | $6.46 | Buy | $6.45 | Buy |
| MA 20 | $6.13 | Buy | $6.20 | Buy |
| MA 50 | $5.52 | Buy | $5.72 | Buy |
| MA 100 | $5.06 | Buy | $5.46 | Buy |
| MA 200 | $5.69 | Buy | $5.13 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 65.68 | Neutral |
| Stoch RSI (14) | 92.39 | Sell |
| CCI (20) | 104.82 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.04 | Buy |
| ROC (12) | 13.56 | Buy |
| Bollinger %B (20,2) | 0.87 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.74 | Buy |
| Awesome (5,34) | 0.73 | Buy |
| Ultimate (7,14,28) | 68.65 | Neutral |
| Momentum (10) | 1.06 | Buy |
| Aroon Osc (25) | 80.00 | Buy |
| Hull MA (9) | 6.72 | Sell |
| ADX (14) | 22.22 | Buy |
| ATR (14) | 0.16 | Info |
The 30-day technical picture is bullish. RSI(14) is 70, and the price sits around $6.70 with the SMA50 at $5.52 and the SMA200 at $5.69. Nearby support is at $5.33 and resistance at $6.70, framing a setup that has recently tested the upper boundary.
The 30-day range runs from $5.52 to $8.13, and annualized volatility is 60%, underscoring notable, but not extreme, price movement.
Market sentiment is described as BULLISH in the near term, consistent with the current price action and indicator readings.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.05 | $6.70 | $10.12 | 0% | Neutral | |
| $8.73 | $11.02 | $14.75 | +65% | Bullish | |
| $10.24 | $13.33 | $18.57 | +99% | Bullish | |
| $11.14 | $14.88 | $21.37 | +122% | Bullish | |
| $13.10 | $17.88 | $26.36 | +167% | Bullish | |
| $14.51 | $20.21 | $30.47 | +202% | Bullish | |
| $16.04 | $22.78 | $35.05 | +240% | Bullish | |
| $21.01 | $30.37 | $47.59 | +353% | Bullish | |
| $24.48 | $35.99 | $57.35 | +437% | Bullish | |
| $27.56 | $41.17 | $66.65 | +515% | Bullish | |
| $41.20 | $66.27 | $114.49 | +889% | Bullish | |
| $86.34 | $157.88 | $299.75 | +22.6x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $4.05 | $6.70 | $7.81 | +0.00% |
| August 2026 | $5.80 | $6.82 | $8.21 | +1.83% |
| September 2026 | $6.07 | $7.20 | $8.80 | +5.60% |
| October 2026 | $6.18 | $7.38 | $9.12 | +2.47% |
| November 2026 | $6.25 | $7.51 | $9.37 | +1.78% |
| December 2026 | $6.66 | $8.05 | $10.12 | +7.11% |
Click any year to see its month-by-month NUVB forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, NUVB could reach as high as $10.12, with a base case around $6.70 and support toward $4.05 — roughly 0% from $6.70. Price action looks broadly range-bound.
Expect NUVB to range from $8.73 to $14.75 through 2027. The $11.02 average target implies a +65% move from current prices. That is up +65% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The NUVB price prediction for 2028 points to an average of $13.33 (low $10.24, high $18.57) — a potential gain of +99% on today's $6.70. Momentum favours further upside here.
In 2029, NUVB is projected to trade between $11.14 and $21.37, averaging $14.88 — a potential gain of +122% from today's $6.70. That is up +12% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Nuvation Bio Inc.'s 2030 outlook centres on $17.88, within a $13.10 to $26.36 range. That is up +20% on the projected 2029 average. That marks a +167% change versus current levels. Momentum favours further upside here.
By 2031, NUVB could reach as high as $30.47, with a base case around $20.21 and support toward $14.51 — roughly +202% from $6.70. Buyers look set to stay in control over this stretch.
Expect NUVB to range from $16.04 to $35.05 through 2032. The $22.78 average target implies a +240% move from current prices. That is up +13% on the projected 2031 average. Momentum favours further upside here.
The NUVB price prediction for 2033 points to an average of $30.37 (low $21.01, high $47.59) — a potential gain of +353% on today's $6.70. Buyers look set to stay in control over this stretch.
In 2034, NUVB is projected to trade between $24.48 and $57.35, averaging $35.99 — a potential gain of +437% from today's $6.70. That is up +19% on the projected 2033 average. Momentum favours further upside here.
Nuvation Bio Inc.'s 2035 outlook centres on $41.17, within a $27.56 to $66.65 range. That is up +14% on the projected 2034 average. That marks a +515% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, NUVB could reach as high as $114.49, with a base case around $66.27 and support toward $41.20 — roughly +889% from $6.70. Momentum favours further upside here.
Expect NUVB to range from $86.34 to $299.75 through 2050. The $157.88 average target implies a +22.6x move from current prices. That is up +138% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in NUVB today (≈ 149.253731 NUVB) could be worth
$23,564.45
+$22,564.45 (+2256%) by 2050 · US Dollar
Based on the average projected NUVB price of $157.88 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NUVBwould be worth at today's price.
$1,000 invested in NUVB on Jul 30, 2025 (≈ 414.937745 NUVB) would be worth
$2,780.08
+$1,780.08 (+178.0%) today · 2.78× · US Dollar
Based on a NUVB entry price of $2.41 vs. today's $6.7.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.49 | $1,032.36 | +3.2% |
| 1 month ago | $5.68 | $1,179.58 | +18.0% |
| 3 months ago | $4.49 | $1,492.2 | +49.2% |
| 6 months ago | $5.24 | $1,278.63 | +27.9% |
| 1 year ago | $2.41 | $2,780.08 | +178.0% |
| All time (5.0y) ago | $8.86 | $756.21 | -24.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NUVB forecast.
Our base-case forecast reaches $13.00 around 2028.
Implied market cap at $13.00: $4.51B
The multi-year forecast shows substantial upside. By 2030 the average price is $17.88, with a min of $13.10 and a max of $26.36, and a bullish sentiment. By 2040 the average is $66.27 and the max is $114.49, with an ROI of 889.1%. By 2050 the average is $157.88 and the max is $299.75, with an ROI of 2256.4%.
The forecast sequence also highlights continued bullish sentiment from 2027 through 2050, with higher average prices each year and increasingly large max targets.
Note that these are estimates and not guarantees; actual outcomes depend on a range of market and company-specific factors.
Tap a question to reveal the answer.
2030 min $13.10, avg $17.88, max $26.36, ROI 166.9, sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward, with rising averages: 2027 avg $11.02, 2028 $13.33, 2029 $14.88, 2030 $17.88, 2040 $66.27, 2050 $157.88, and ROI figures such as 64.5% in 2027, 99% in 2028, 122% in 2029, 166.9% in 2030, and higher thereafter.
Yes. The forecast max reaches $114.49 in 2040 and $299.75 in 2050.
min $41.20, avg $66.27, max $114.49, ROI 889.1%, sentiment BULLISH.
min $86.34, avg $157.88, max $299.75, ROI 2256.4%, sentiment BULLISH.
Nuvation Bio Inc. Community Discussion
0Share your Nuvation Bio Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.